Company / Total Assets
Century Therapeutics, Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$223.7M
FY2025
5-year range
$223.7M / $486.5M
FY2022-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $487M in FY2022 to $224M in FY2025.
Based on SEC 10-K filings.
$224M in FY2025 with a 3-year CAGR of -22.8%.
Declined from $361M to $224M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -22.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Century Therapeutics, Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -22.8%, indicating a declining trend.
- In FY2025, total assets decreased 36.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $223.7M | -36.7% |
| FY2024 | $353.2M | -2.1% |
| FY2023 | $360.7M | -25.9% |
| FY2022 | $486.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026